Frontlight ResearchEarly access
Mesothelioma trials in Belgium
2 of 3 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleIntegration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma
- Where
- Edegem, Gent, Sint-Niklaas
- Age
- 18 years and over
- People
- 15
- Run by
- University Hospital, Antwerp
See details and how to joinNCT05765084 · EU 2024-515293-27-00 - Phase 1/2Taking peopleNEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study
- Where
- Edegem, Gent
- Age
- 18 years and over
- People
- 37
- Run by
- University Hospital, Antwerp
See details and how to joinNCT07121374 · EU 2023-504302-11-02